Remove 2023 Remove Digital Health Remove Drug Development Remove Health Data
article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. 2021 [6] Regina M.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”